Advertisement

WuXi Biologics plunges again in setback for Hong Kong market while Li Auto, Geely lead EV surge on strong deliveries

  • China approved 32 imported online games on Thursday in a sign of its softening stance on the industry
  • Li Auto and Geely rose after recording increases of 58 to 110 per cent in January deliveries versus year-ago levels

Reading Time:2 minutes
Why you can trust SCMP
13
People walking outside a building with running stock tickers in Tsim Sha Tsui, Hong Kong on November 21, 2023. Photo: Li Jiaxing
Zhang Shidongin Shanghai
Hong Kong stocks capped another weekly loss on renewed concerns about geopolitical risks following a proposed US legislation targeting Chinese biotechnology firms. WuXi Biologics and WuXi AppTec slumped anew, losing about one-fifth of their market value.
Advertisement

The Hang Seng Index dropped 0.2 per cent to 15,533.56 at the close, erasing an earlier rally of as much as 2.2 per cent and taking the loss for the week to 2.6 per cent. The Tech Index slipped 0.7 per cent, reversing a 3.3 per cent gain, while the Shanghai Composite Index slipped 1.5 per cent.

WuXi Biologics plunged 21 per cent to HK$16.78, while its affiliate WuXi AppTec tumbled by the same magnitude to HK$43.70. Both stocks slumped 32 per cent this week after a US lawmaker moved a bill to block Chinese biotech firms from doing business with the US government.

Alibaba Group fell 0.5 per cent to HK$70.70 and e-commerce rival JD.com lost 1.7 per cent to HK$86. Baidu shed 0.8 per cent to HK$102 and Hong Kong Exchanges and Clearing dropped 1.4 per cent to HK$233.40.

“There has been no significant improvement in fundamentals and that is exacerbating market sentiment to cause the persistent declines,” said Shen Fanchao, an analyst at Zheshang International. “We are cautious about Hong Kong stocks in the near term, and the key to breaking this bad cycle is more state policy support.”

Advertisement

The Hang Seng Index is the worst performer among major equity benchmarks this year, with a loss of 8.9 per cent. A lack of forceful stimulus and the Federal Reserve’s reluctance to cut rates have clouded the market outlook. China’s manufacturing shrank for a fourth month in January, the statistics bureau said this week.

Advertisement